IP Verse

Compositions And Methods For Modulating Gene Expression - EP2850189B8

PatentPatent Analysis

EP2850189

RANA THERAPEUTICS
Application Number
EP13791343A
Filing Date
May 16, 2013
Status
Revoked
Apr 30, 2021
Grant Date
Jan 23, 2019
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2850189B8 was granted to Rana Therapeutics on Jan 23, 2019 following the initial filing on May 16, 2013 under the application number EP13791343A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ROCHE INNOVATION CENTER COPENHAGENAug 2, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents